Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
(1) This peptide appears to be naturally present in the bloodstream and has been suggested as a potential element in regulating the growth, development, and apoptosis of vascular endothelial cells
Important Notes These are the points most often dropped when AHK-Cu is marketed as an injectable hair-growth peptide. No human trial exists state it plainly: there is no clinical trial of AHK-Cu by any route, and the entire peptide-specific peer-reviewed base is one 2007 study that was ex vivo and in vitro [1]
Some research protocols have explored doses up to 4.5 mg weekly, which showed slightly greater efficacy in the phase 2 dose-finding trial but also increased side effect burden
High dosages can get you mild side effects like diarrhea, nausea, dizziness, headaches, or a very warm burning feeling in the injection area
Systemic Half-Life: The systemic half-life of injectable BPC-157 is relatively short, estimated to be between 4 and 6 hours
Tendinitis Sucks as well as being shadow-banned - Using BPC-157 has shown to accelerate the healing process, especially with ligaments and tendons
